| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.076 | 0.7 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |